Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pfister

Showing results (21-30 of 194) with videos related to

Pageof 20
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 18, 2014
Process for protein PEGylationDavid Pfister, Massimo Morbidelli
Journal of Chromatography. A|December 16, 2014
Linear isotherm determination from linear gradient elution experimentsDavid Pfister, Fabian Steinebach, Massimo Morbidelli
European Urology|August 29, 2016
Re: Pattern of Progression After Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal RecurrencesDaniel Porres, Axel Heidenreich, David Pfister
Translational Andrology and Urology|February 15, 2020
Testis-preserving strategies in testicular germ cell tumors and germ cell neoplasia <i>in situ</i>Pia Paffenholz, David Pfister, Axel Heidenreich
Targeted Oncology|November 1, 2016
New Biomarkers for Selecting the Best Therapy Regimens in Metastatic Castration-Resistant Prostate CancerIsabel Heidegger, Axel Heidenreich, David Pfister
Aktuelle Urologie|August 22, 2023
[Emergencies in cancer therapy: surgical indications under systemic therapy]Constantin Rieger, David Pfister, Axel Heidenreich
European Urology|May 3, 2026
Management of Testicular Germ Cell Tumours: Personalised Treatment Approaches Are on Their WayAxel Heidenreich, Julian Heidenreich, David Pfister
European Urology Focus|July 21, 2017
Repeat Prostate Biopsy: Rationale, Indications, and StrategiesUmberto Capitanio, David Pfister, Mark Emberton
Journal of Chromatography. A|December 2, 2015
Optimization of reversed-phase chromatography methods for peptide analyticsRushd Khalaf, Daniel Baur, David Pfister
European Urology Oncology|August 6, 2019
Primary Retroperitoneal Lymph Node Dissection or Chemotherapy in Nonseminomas with Low-Volume Metastatic Disease: Experience MattersAxel Heidenreich, Pia Paffenholz, David Pfister
Pageof 20

Showing results (21-30 of 194) with videos related to

Sort By:
Pageof 20
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 18, 2014
Process for protein PEGylationDavid Pfister, Massimo Morbidelli
Journal of Chromatography. A|December 16, 2014
Linear isotherm determination from linear gradient elution experimentsDavid Pfister, Fabian Steinebach, Massimo Morbidelli
European Urology|August 29, 2016
Re: Pattern of Progression After Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal RecurrencesDaniel Porres, Axel Heidenreich, David Pfister
Translational Andrology and Urology|February 15, 2020
Testis-preserving strategies in testicular germ cell tumors and germ cell neoplasia <i>in situ</i>Pia Paffenholz, David Pfister, Axel Heidenreich
Targeted Oncology|November 1, 2016
New Biomarkers for Selecting the Best Therapy Regimens in Metastatic Castration-Resistant Prostate CancerIsabel Heidegger, Axel Heidenreich, David Pfister
Aktuelle Urologie|August 22, 2023
[Emergencies in cancer therapy: surgical indications under systemic therapy]Constantin Rieger, David Pfister, Axel Heidenreich
European Urology|May 3, 2026
Management of Testicular Germ Cell Tumours: Personalised Treatment Approaches Are on Their WayAxel Heidenreich, Julian Heidenreich, David Pfister
European Urology Focus|July 21, 2017
Repeat Prostate Biopsy: Rationale, Indications, and StrategiesUmberto Capitanio, David Pfister, Mark Emberton
Journal of Chromatography. A|December 2, 2015
Optimization of reversed-phase chromatography methods for peptide analyticsRushd Khalaf, Daniel Baur, David Pfister
European Urology Oncology|August 6, 2019
Primary Retroperitoneal Lymph Node Dissection or Chemotherapy in Nonseminomas with Low-Volume Metastatic Disease: Experience MattersAxel Heidenreich, Pia Paffenholz, David Pfister
Pageof 20